AvKare LLC awarded $8,628,888 contract for estradiol tablets
United States, Sept. 16 -- AvKare LLC, Pulaski, Tennessee, has been awarded an estimated $8,628,888 modification (P00009) exercising the third one-year option period of a one-year base contract (SPE2D2-23-D-0001) with four one-year option periods for estradiol tablets. This is a fixed-price, requirements contract. Locations of performance are Kentucky and New York, with an Oct. 3, 2026, performance completion date. Using customers are Army, Navy, Air Force, Marine Corps, Coast Guard, Department of Veterans Affairs, Indian Health Services, and Federal Bureau of Prisons. Type of appropriation is fiscal 2026 through 2027 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylva...
To read the full article or to get the complete feed from this publication, please
Contact Us.